Effect of Intraoperative Remifentanil Infusion Rate on Postoperative Tolerance and Analgesic Consumption in Pediatric Laparoscopic Ureteroneocystostomy

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01147757

Enrollment

Registered

2010-06-22

Start date

2010-06-30

Completion date

2012-06-30

Last updated

2011-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatrics

Keywords

pediatric patients (ASA physical status I or II) aged between

Brief summary

Effect of intraoperative remifentanil infusion rate on postoperative tolerance and analgesic consumption in pediatric laparoscopic ureteroneocystostomy.

Interventions

DRUGremifentanil

During surgery, 3 different dose of remifentanil or placebo was infused.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Masking

DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender

ALL

Age

1 Years to 5 Years

Healthy volunteers

Inclusion criteria

* Pediatric patients (ASA physical status I and II) aged between 1-5 yrs and scheduled elective laparoscopic ureteroneocystostomy

Exclusion criteria

* cardiovascular, renal, liver disease or growth retardation

Design outcomes

Primary

Measure	Time frame
fentanyl consumption for IV-PCA	24 h and 48 h after surgery
Postoperative pain score	during 48 h after surgery

Countries

South Korea

Contacts

Primary ContactJeong-Yeon Hong

jenyhongg@hanmail.net

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026